Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-09-09

Clinical Trial Update: Phase II Study of Growth Hormone in Children With Cystic Fibrosis [Phase 2]

View source ↗

Summary

The document reports that a Phase II study of growth hormone in children with cystic fibrosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Growth Hormone (somatropin)

Snippet

Sponsor: University of Utah | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED